Kun-Long Hung | Personalized Medicine | Top Pharmaceutical Breakthrough Discovery Award

Published on by Top Pharmaceutical

Top Pharmaceutical Breakthrough Discovery Award

Kun-Long Hung
Fu Jen Catholic University Hospital, Taiwan

Kun-Long Hung
Affiliation Fu Jen Catholic University Hospital
Country Taiwan
Scopus ID 7202728402
Documents 81
Citations 1,862
h-index 23
Subject Area Personalized Medicine
Event International Top Pharmaceutical Awards

Kun-Long Hung is a Taiwanese clinician and researcher associated with Fu Jen Catholic University Hospital. His scholarly record demonstrates sustained contributions to personalized medicine, pediatric neurology, genetic disorders, developmental diseases, and translational healthcare research. According to Scopus metrics, his publication portfolio includes more than eighty indexed documents and a substantial citation impact within the medical research community.[1]

Abstract

This article summarizes the academic profile and scientific achievements of Kun-Long Hung. His research activities have focused on personalized medicine approaches, pediatric neurological disorders, genetic diagnostics, and evidence-based clinical practice. Through multidisciplinary collaborations, he has contributed to improved understanding of rare diseases and patient-centered healthcare strategies.[1]

Keywords

Personalized Medicine, Pediatric Neurology, Genetic Disorders, Clinical Research, Rare Diseases, Translational Medicine, Precision Healthcare, Developmental Disorders, Neurogenetics, Medical Innovation.

Introduction

The advancement of personalized medicine depends on researchers who integrate clinical observations with scientific investigation. Kun-Long Hung has participated in studies addressing neurological and genetic conditions affecting children and families. His published work reflects an ongoing commitment to improving diagnostic accuracy and therapeutic decision-making in modern healthcare environments.[2]

Research Profile

Based in Taiwan, Hung has established a recognized publication record supported by 81 indexed documents, 1,862 citations, and an h-index of 23. His research portfolio spans neurodevelopmental disorders, pediatric epilepsy, genetic syndromes, and precision medicine applications. These metrics indicate consistent scholarly engagement and meaningful influence across multiple areas of clinical medicine.[1]

Research Contributions

Hung has contributed to investigations involving developmental delay, neurofibromatosis, Dravet syndrome, tubulinopathy, and other neurological disorders. His work frequently combines genetic evaluation with clinical assessment to support individualized treatment planning. Such contributions align closely with contemporary precision medicine objectives and patient-focused healthcare models.[3]

Publications

Among his notable publications are studies on neurofibromatosis management in Taiwan, neurological manifestations of SARS-CoV-2 infection in children, developmental delay diagnostics, and rare genetic disorders. These publications demonstrate continued participation in clinically relevant research that addresses both local and international healthcare challenges while supporting evidence-based practice.[2]

Research Impact

The citation performance associated with Hung’s publications reflects engagement from researchers across medical and scientific disciplines. His studies have contributed to discussions involving diagnosis, disease management, and long-term outcomes in pediatric populations. This influence supports continued visibility within international biomedical literature and healthcare research communities.[1]

Award Suitability

The International Top Pharmaceutical Awards recognize researchers whose work advances healthcare innovation and scientific understanding. Hung’s contributions to personalized medicine, combined with his publication record and citation impact, align with the objectives of recognizing meaningful research achievements. His work illustrates the integration of clinical expertise and translational investigation.[4]

Conclusion

Kun-Long Hung has developed a substantial academic profile through research focused on pediatric neurology, genetic medicine, and individualized healthcare. His scientific contributions, publication metrics, and collaborative activities demonstrate continued involvement in advancing medical knowledge. These achievements provide a strong foundation for recognition within international research and healthcare award programs.

References

  1. Elsevier. (n.d.). Scopus Author Profile: Hung, K. L. (Author ID: 7202728402). Scopus. https://www.scopus.com/authid/detail.uri?authorId=7202728402
  2. Chu, Y. J., Wong, L. C., Ho, C. S., Lee, W. T., & Hung, K. L. (2024). Neurological manifestations of SARS-CoV-2 infection in children in Taiwan: A cross-sectional multicenter study. Journal of the Formosan Medical Association. https://doi.org/10.1016/j.jfma.2024.01.001
  3. Huang, C. S., Hung, P. L., Fan, P. C., Lee, W. T., & Hung, K. L. (2021). Clinical spectrum and comorbidities of Dravet syndrome in Taiwan and possible molecular mechanisms. Scientific Reports, 11, Article 15092. https://pubmed.ncbi.nlm.nih.gov/34642351/
  4. Hung, K. L., Lu, J. F., Su, D., Hsu, S., & Wong, L. C. (2022). Tubulinopathy presenting as developmental and epileptic encephalopathy. Children, 9(11), 1663. https://doi.org/10.3390/children9111663
  5. Liang, J. S., Hung, K. L., Lin, L., Keng, W. T., & Lu, J. F. (2023). Novel PEX1 mutations in fibroblasts from children with Zellweger spectrum disorders exhibit temperature-sensitive characteristics. Epilepsy & Behavior, 147, 109387. https://doi.org/10.1016/j.yebeh.2023.109387

Olfa Trabelsi | Personalized Medicine | Women Researcher Award

Published on by Top Pharmaceutical

Women Researcher Award

Olfa Trabelsi
University of Technology of Compiègne, France

Olfa Trabelsi
Affiliation University of Technology of Compiègne
Country France
Scopus ID 36025990200
Documents 29
Citations 685
h-index 13
Subject Area Personalized Medicine
Event International Top Pharmaceutical Awards
ORCID 0000-0003-4415-8478

Olfa Trabelsi is a researcher affiliated with the University of Technology of Compiègne in France and is recognized for interdisciplinary research activities within biomedical engineering and personalized medicine. Her academic work combines computational mechanics with biological applications and demonstrates integration between engineering concepts and medical analysis. Bibliometric indicators and publication records indicate continuing contributions in tissue engineering and patient-specific modeling studies.[1]

Abstract

This article summarizes the academic profile and scientific contributions associated with Olfa Trabelsi. Research activities mainly involve computational biomechanics, tissue engineering applications, and biomedical modeling methodologies. Scientific outputs further indicate interdisciplinary collaborations designed to improve analytical approaches used in personalized medical systems and healthcare technologies.[2]

Keywords

Personalized Medicine, Biomedical Engineering, Biomechanics, Tissue Engineering, Computational Modeling, Medical Simulation, Patient-Specific Analysis.

Introduction

Current advances in healthcare increasingly rely on computational and patient-centered methodologies for diagnostic and therapeutic improvements. Olfa Trabelsi has participated in research environments involving biomedical analysis and engineering applications designed for clinical relevance. Such studies contribute toward the understanding of tissue behavior and individualized medical systems.[3]

Research Profile

According to ORCID records, Olfa Trabelsi currently serves as an Associate Professor at the University of Technology of Compiègne and has academic experience in biomechanics and computational mechanics research. Educational activities include doctoral studies in computational mechanics and multidisciplinary biomedical applications.[4]

Research Contributions

Research contributions include computational analysis of biological tissues, mechanical characterization studies, and predictive modeling techniques. Published investigations have focused on tracheal systems, vascular biomechanics, tissue remodeling processes, and personalized therapeutic assessment methods.[5]

Publications

Publication records demonstrate collaborative research across multiple biomedical disciplines and engineering frameworks. Scientific articles include computational bone remodeling studies, tissue engineering analysis, aneurysm prediction models, and tracheal mechanical simulations. Published works further illustrate integration between clinical requirements and engineering methodologies within patient-specific biomedical systems.

Research Impact

Citation statistics indicate measurable influence across scientific communities and interdisciplinary domains. The available bibliometric indicators suggest continuing relevance of published work and recognition through citations, collaborative outputs, and international dissemination activities.

Award Suitability

Academic metrics and scientific activities suggest alignment with criteria commonly associated with international research recognition programs. Contributions involving personalized medicine and biomedical technologies support consideration within broader scientific achievement categories.

Conclusion

Olfa Trabelsi represents an academic profile characterized by multidisciplinary investigation and continuing scientific activity. Research outputs demonstrate integration of engineering principles with healthcare technologies and support continuing development of personalized biomedical systems.

References

  1. Trabelsi, O., Duprey, A., Favre, J.P., & Avril, S. (2016). Predictive models with patient specific material properties for the biomechanical behavior of ascending thoracic aneurysms. Annals of Biomedical Engineering.
    https://doi.org/10.1007/s10439-015-1374-8
  2. Trabelsi, O., Davis, F.M., Rodriguez-Matas, J.F., Duprey, A., & Avril, S. (2015). Patient specific stress and rupture analysis of ascending thoracic aneurysms. Journal of Biomechanics.
    https://doi.org/10.1016/j.jbiomech.2015.04.035
  3. Trabelsi, O., et al. (2022). A simple and effective 1D-element discrete-based method for computational bone remodeling. Computer Methods in Biomechanics and Biomedical Engineering.
    https://doi.org/10.1080/10255842.2021.1943370
  4. Trabelsi, O., et al. (2020). In vitro histomechanical effects of enzymatic degradation in carotid arteries during inflation tests with pulsatile loading. Journal of Mechanical Behavior of Biomedical Materials.
    https://doi.org/10.1016/j.jmbbm.2019.103550
  5. Ruben, R.B., Carvalho, M., & Trabelsi, O. (2026). Biomechanics Analysis in Tissue Engineering. Bioengineering.
    https://doi.org/10.3390/bioengineering13060703

Jonathan Ejie | Personalized Medicine | Best Research Article Award

Published on by Top Pharmaceutical

Jonathan Ejie | Personalized Medicine | Best Research Article Award

Mr. Jonathan Ejie, UCSF, United States

Mr. Jonathan Ejie is an aspiring physician-scientist currently pursuing his M.D. at UCSF 🩺 (Class of 2026), following a B.S. in Electrical Engineering & Computer Science from UC Berkeley 💻. His research spans oncology, radiology, and AI in healthcare, with published work in Cancers (2025) and upcoming studies in Nature Communications 📊. Jonathan integrates data science 🧠 with clinical insights, contributing to health equity, quality improvement, and surgical education. A mentor, tutor, and award-winning leader 🏅, he co-founded the UCSF Futbol Club and serves underserved communities through advocacy and outreach.

Publication Profile 

Orcid

Education

Mr. Jonathan Ejie is an exceptional scholar whose educational journey bridges medicine and technology. He is currently pursuing his Doctor of Medicine (M.D.) degree at the prestigious University of California, San Francisco (UCSF) 🏥, with an expected graduation in 2026. Prior to this, he earned a Bachelor of Science in Electrical Engineering and Computer Science (EECS) 💻 from the University of California, Berkeley, graduating in 2022. His strong foundation in both engineering and clinical science equips him with a unique interdisciplinary perspective 🤖🩺, positioning him at the forefront of innovation in digital health and precision medicine.

Experience

Mr. Jonathan Ejie brings a blend of academic support and compassionate service to his professional journey. As an MCAT Physics Tutor at UCSF (2023), he guided 15+ students through complex physics concepts 📘⚛️. Earlier, at Contra Costa College (2019–2021), he tutored mathematics from Algebra to Calculus ➕📐. His volunteer work includes providing first aid at athletic events 🏃‍♂️🩹, teaching surgical skills to high school students at UCSF 🧵🧑‍⚕️, and serving as a Health Advocate at West County Health Center 💬🩺, helping underserved patients access vital community resources. His dedication reflects a strong commitment to both education and public health.

Awards

Mr. Jonathan Ejie has been recognized for his academic excellence and impactful contributions to medicine and research. In 2024, he was honored with the prestigious Sinkler Miller Medical Association Scholarship 🎖️, sponsored by Gilead, celebrating his commitment to health equity and academic distinction. He also received the UCSF School of Medicine Summer Explore Fellowship Grant 🌟, supporting his innovative pursuits in medical research. In May 2023, Jonathan earned the Inquiry Conference Travel and Dissemination Award ✈️📊, which enabled him to share his scholarly findings on a larger stage. These accolades reflect his rising potential and leadership in healthcare.

Research Focus 

Mr. Jonathan Ejie’s research focus lies at the intersection of oncology, health disparities, and medical data science. His standout work on the “Ongoing Failure to Deliver Guideline-Concordant Care for Patients with Pancreatic Cancer” 📉🩺 highlights critical inequities in healthcare delivery across race, geography, and insurance status. Combining his background in medicine 🧑‍⚕️ and computer science 💻, Jonathan leverages data analysis and machine learning 🤖📊 to drive systemic improvements in cancer care. His work reflects a commitment to equity, evidence-based medicine, and the pursuit of personalized, accessible treatment strategies for vulnerable cancer populations.

Publication Top Notes

  • Ongoing Failure to Deliver Guideline-Concordant Care for Patients with Pancreatic Cancer

Jose M. Soriano | Precision Medicine | Best Researcher Award

Published on by Top Pharmaceutical

Jose M. Soriano | Precision Medicine | Best Researcher Award

Prof Jose M. Soriano, University of Valencia, Spain

Prof. José M. Soriano is a Full Professor at the Faculty of Pharmacy, Universitat de València, specializing in food safety, toxicology, and nutrition. He holds a Ph.D. in Food Safety and Toxicology (2001) and degrees in Pharmacy (1996) and Human Nutrition and Dietetics (2018). He has led over 50 national and international projects and published 199 journal articles. With an impressive citation index of 5,263, Prof. Soriano is also Editor-in-Chief of the Spanish Journal of Human Nutrition and Dietetics and has published 50 books. His research focuses on nutraceutics, food safety, and toxicology. 📚🍏🔬

Publication Profile

Google Scholar

Academic Background

Prof. José M. Soriano holds a doctorate in Food Safety and Toxicology, along with degrees in Pharmacy and Human Nutrition. With extensive experience in pharmacy, food science, and nutrition research, he is a Full Professor at Universitat de València. His expertise covers critical areas such as food safety, toxicology, and nutrition, where he contributes to advancing scientific understanding. Prof. Soriano’s work bridges academia and practical application, ensuring a deep impact on public health and safety. 🍏🔬📚

Research and Innovations

Prof. José M. Soriano is a distinguished researcher with extensive expertise in food safety, nutrition, and toxicology. He has led over 50 national and international projects, significantly advancing scientific understanding in these critical areas. With more than 5,200 citations and 199 publications in renowned journals, his work has made a lasting impact. Prof. Soriano’s involvement in over 20 consultancy and industry projects further highlights the practical application of his research. His contributions continue to shape the fields of food safety and toxicology, ensuring better public health and informed industry practices. 📚🔬🌍🥗🧬

Editorial and Collaborative Roles

Prof. José M. Soriano is a renowned expert in human nutrition and dietetics, currently serving as the Editor-in-Chief of the Spanish Journal of Human Nutrition and Dietetics. Through his leadership and extensive collaborations with prestigious institutions across Africa and Asia, he actively contributes to advancing research and education in the field. Prof. Soriano’s dedication to improving global health, particularly through nutrition, has earned him recognition across continents. His work plays a significant role in fostering knowledge exchange and implementing impactful solutions in diverse healthcare settings. 🌍🍏📚💡👨‍⚕️

Professional Recognition

Prof. José M. Soriano is highly esteemed within the scientific community, evident through his memberships in prestigious organizations like the Spanish Academy of Nutrition and Dietetics and the Academy of Pharmacy of the Valencian Community. His recognition in these influential bodies reflects his significant contributions to the fields of nutrition, dietetics, and pharmacy. Through his work, Prof. Soriano has earned respect and credibility, underscoring his dedication to advancing knowledge and practices in these vital areas. His ongoing involvement with these academies is a testament to his ongoing impact and influence. 👨‍⚕️📚🏅

Research Focus

Based on the provided research publications, the individual appears to focus primarily on food safety and toxicology, with a particular interest in mycotoxins and their effects on human health. Their work spans areas like the toxicity, occurrence, and detoxification of mycotoxins such as aflatoxins, zearalenone, and fumonisins. Additionally, they have explored the mechanisms of action of sphingolipids in toxicity, food contamination, and microbiological quality in food products like lettuce and milk. This researcher is also involved in studies on obesity and nutrition, highlighting their expertise in both food toxicology and clinical nutrition. 🧪🍽️🔬🦠

Publication Top Notes

Review on the toxicity, occurrence, metabolism, detoxification, regulations and intake of zearalenone: an oestrogenic mycotoxin

Mechanism of action of sphingolipids and their metabolites in the toxicity of fumonisin B1

Presence of aflatoxin M1 in pasteurized milk from Morocco

Determination of aflatoxins in peanuts by matrix solid-phase dispersion and liquid chromatography

Assessment of the microbiological quality and wash treatments of lettuce served in University restaurants

Incidence of ochratoxin A in rice and dried fruits from Rabat and Salé area, Morocco

Incidence of microbial flora in lettuce, meat and Spanish potato omelette from restaurants

 

 

Mrs. Ana Catarina Sousa| Personalized Medicine|Best Researcher Award

Published on by Top Pharmaceutical

Mrs. Ana Catarina Sousa| Personalized Medicine|Best Researcher Award

Mrs. Ana Catarina Sousa at School of Medicine and Biomedical Sciences – University of Porto (ICBAS),Portugal

PROFILE  

Google scholar

Early Academic Pursuits 🎓

Ana Catarina Soares de Sousa’s academic journey is marked by a strong focus on the intersection of healthcare and engineering. She completed her Master’s degree in Health Services Management and Economics in 2021 at the prestigious University of Porto, one of the top academic institutions in Portugal. This degree provided her with in-depth knowledge of the economic and managerial aspects of healthcare services, a vital skill set for navigating the complexities of healthcare systems and improving service delivery.

Prior to this, she earned a Master’s degree in Integrated Master in Bioengineering in 2018 at the same university. This program combined principles of biology, medicine, and engineering, equipping her with a solid foundation in biomedical engineering—particularly crucial for her subsequent research on biomaterials and medical technologies. Her dual educational background uniquely positions her to address both the technical and systemic challenges in health services, a hallmark of her later work.

Since 2020, Ana Catarina has been pursuing a PhD in Biomedical Sciences at the Abel Salazar Institute of Biomedical Sciences (ICBAS) within the University of Porto. Her PhD program focuses on interdisciplinary research in medical and health sciences, allowing her to build on her expertise in biomaterials and tissue engineering, while contributing to innovations in medical biotechnology.

Professional Endeavors 💼

Ana Catarina’s professional journey reflects a commitment to both research and practical applications in the biomedical sciences. Throughout her career, she has participated in numerous research projects, taking on key roles both as a research fellow and a lead researcher. Since 2018, she has contributed to seven major research projects, focusing on cutting-edge biomedical technologies and solutions for healthcare challenges.

Among her significant projects are:

  • InnovaBIOMAS (2023–2026): An innovative biofabrication system for creating multi-tissue scaffolds for joint disease treatments. This project highlights her expertise in biomaterials and tissue engineering.
  • H2Cure (2021–2024): A project developing novel formulations, including honey-based gels and dressings with gelan gum and hyaluronic acid for wound care—an intersection of regenerative medicine and biotechnology.
  • PRECOGFIL (2020–2024): This initiative explores the development of pre-tensioned cog threads for transvaginal repair of compartment prolapse, showing her application of bioengineering in women’s health.
  • Bone2Move (2018–2021): Focused on 4D scaffolds for bone defect repair, it underscores her involvement in the evolution of tissue engineering techniques.

Her work has crossed the boundaries of disciplines, spanning medical technology, veterinary applications, regenerative medicine, and materials engineering.

Contributions and Research Focus 🔬

Ana Catarina’s contributions to the biomedical field have been prolific. With 30 peer-reviewed journal articles and 2 book chapters, she has established herself as a thought leader in the scientific community. Her research encompasses a range of fields, but she is particularly recognized for her work in Medical Biotechnology, with a specific emphasis on biomaterials and tissue engineering.

Some of the key areas of her research include:

  • Regenerative Medicine: Her focus on developing advanced biomaterials that can aid in tissue regeneration and healing has practical applications in orthopedics, wound care, and surgical interventions.
  • Veterinary Medicine: Her interdisciplinary approach extends into veterinary science, where she applies biomedical engineering techniques to animal health.
  • Translational Medicine: Ana Catarina is committed to bridging the gap between laboratory research and clinical applications, ensuring that her discoveries can have a real-world impact on patient care.
  • Sustainable Chemistry: She has also been involved in developing environmentally friendly materials and chemical processes for healthcare applications, contributing to sustainability in medical technology.
  • Chemistry for Health: Her work in this area includes the development of biomaterials and formulations aimed at improving health outcomes through innovative chemistry.

With 214 co-authors in her published works, she has demonstrated an impressive ability to collaborate across disciplines and with researchers from around the world.

Accolades and Recognition 🏆

Ana Catarina’s work has not gone unnoticed. She has been the recipient of one award that recognizes her contributions to the field of biomedical sciences. This accolade highlights her innovative approach to healthcare challenges and her ability to bring together diverse disciplines in pursuit of improved health outcomes.

In addition to her award, she has also been instrumental in the scientific community as an event organizer. She has successfully organized three major events, bringing together researchers, healthcare professionals, and industry experts to discuss the latest advancements in biomedical sciences and medical technologies.

Impact and Influence 🌍

Ana Catarina’s work in biomedical sciences has the potential to make a far-reaching impact on both human and animal health. By focusing on innovative biomaterials and medical biotechnology, she is contributing to the development of new treatments that could transform the way diseases are managed and treated. Her research on scaffold-based tissue regeneration and wound care formulations has implications for patients suffering from joint diseases, chronic wounds, and surgical complications.

Her work in the development of advanced biofabrication systems and pre-tensioned threads for surgical repairs also promises to improve surgical outcomes and post-surgical recovery for patients. Moreover, her focus on sustainable chemical processes ensures that her contributions are not only medically valuable but also environmentally responsible.

Legacy and Future Contributions 🌟

Looking ahead, Ana Catarina is poised to continue making groundbreaking contributions to the field of biomedical sciences. Her ongoing projects, particularly those related to biomaterials for regenerative medicine, have the potential to lead to new therapies that will benefit both human and veterinary medicine.

Her focus on translational research ensures that her work will continue to have a direct impact on clinical practices, making her a key figure in the future of medical biotechnology. As she progresses in her PhD journey and beyond, Ana Catarina Soares de Sousa is likely to leave a lasting legacy in the fields of tissue engineering and healthcare innovation.

In the years to come, her work is expected to influence not only scientific research but also the development of new medical technologies that will improve patient care and healthcare systems around the world.

🎓Publication 

Peripheral nerve injury treatments and advances: one health perspective

  • Authors   :Bruna Lopes, Patrícia Sousa, Rui Alvites, Mariana Branquinho, Ana Catarina Sousa, Carla Mendonça, Luís Miguel Atayde, Ana Lúcia Luís, Artur SP Varejão, Ana Colette Maurício
  • Journal    :International journal of molecular sciences
  • Year         :2022

Dental pulp stem cells and Bonelike® for bone regeneration in ovine model

  • Authors   : JM Campos, AC Sousa, AR Caseiro, SS Pedrosa, PO Pinto, MV Branqu
  • Journal    :Regenerative biomaterials
  • Year         :2019

Mesenchymal stem/stromal cells and their paracrine activity—immunomodulation mechanisms and how to influence the therapeutic potential

  • Authors   : Rui Alvites, Mariana Branquinho, Ana C Sousa, Bruna Lopes, Patrícia Sousa, Ana Colette Maurício
  • Journal    :Pharmaceutics
  • Year         :2022

Assessment of the environmental impacts of medical devices: a review

  • Authors   :Ana Catarina Sousa, Anabela Veiga, Ana Collete Maurício, Maria Ascensão Lopes, José Domingos Santos, Belmira Neto
  • Journal    :Environment, Development and Sustainability
  • Year         :2021

Combined Use of Chitosan and Olfactory Mucosa Mesenchymal Stem/Stromal Cells to Promote Peripheral Nerve Regeneration In Vivo

  • Authors   :Rui D Alvites, Mariana V Branquinho, Ana C Sousa, Irina Amorim, Rui Magalhães, Filipa João, Diogo Almeida, Sandra Amado, Justina Prada, Isabel Pires, Federica Zen, Stefania Raimondo, Ana L Luís, Stefano Geuna, Artur SP Varejão, Ana C Maurício
  • Journal    :Stem cells international
  • Year         :2021